Format

Send to

Choose Destination
See comment in PubMed Commons below
Cell Cycle. 2007 May 2;6(9):1006-10. Epub 2007 May 28.

p53: guardian of the genome and policeman of the oncogenes.

Author information

1
Tumor Suppression Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.

Abstract

The process of malignant transformation universally entails genetic damage and oncogenic signaling, two stresses that are signaled to p53 through different genetic pathways. Based on this, it is possible to distinguish two jobs for p53: "guardian of the genome" that consists in sensing and reacting to DNA damage through the ATM/ATR and Chk1/Chk2 kinases, and "policeman of the oncogenes" that, correspondingly, consists in responding to oncogenic signaling through the p53-stabilizing protein ARF. Contrary to expectation, recent genetic evidence in mice indicates that the response of p53 to DNA damage has little or no impact on cancer protection. In contrast, ARF-dependent activation of p53 is critical for p53-mediated tumor suppression. Here, we discuss the mechanistic implications of these observations and their relevance for cancer therapy.

PMID:
17457049
DOI:
10.4161/cc.6.9.4211
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center